Monday, November 9, 2026
  • Login
CEO North America
  • Home
  • News
    • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel
No Result
View All Result
  • Home
  • News
    • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel
No Result
View All Result
CEO North America
No Result
View All Result

CEO NA Magazine > News > CVS, Walmart and Walgreens Agree to Pay $13.8 Billion for Opioid Claims

CVS, Walmart and Walgreens Agree to Pay $13.8 Billion for Opioid Claims

in News
CVS, Walmart and Walgreens Agree to Pay $13.8 Billion for Opioid Claims
Share on LinkedinShare on WhatsApp

CVS Health, Walgreens Boots Alliance and Walmart have agreed to pay about $13.8 billion to resolve thousands of lawsuits accusing the pharmacy chains of mishandling opioid painkillers.

In a filing with the Securities and Exchange Commission Walgreens disclosed that it had agreed to pay about $5.7 billion over 15 years. CVS said Wednesday it had agreed to pay about $5 billion over 10 year and Walmart has agreed to pay $3.1 billion, according to two people familiar with the matter.

Neither company admitted wrongdoing.

CVS, Walgreens and Walmart are the three largest retail pharmacies in the country by market share.

“We are pleased to resolve these longstanding claims and putting them behind us is in the best interest of all parties, as well as our customers, colleagues and shareholders,” CVS’s general counsel, Thomas Moriarty, said in a statement. The company did not admit wrongdoing.

Walgreens said in its SEC filing that it “continues to believe it has strong legal defenses” and will defend itself against any future lawsuits not covered by the settlement.

In more than 3,300 lawsuits, beginning in 2017, state and local governments accused drugmakers of downplaying the risks of their opioid pain medicines. Pharmacies were accused of ignoring red flags that prescriptions were being diverted into illegal trafficking.

Overdoses involving opioids, including prescription pills and heroin, surged further during the Covid pandemic, increasing 38% in 2020 over the previous year and another 15% in 2021, according to the Centers for Disease Control and Prevention.

Tags: CVS HealthopioidsWalgreensWalmart

Related Posts

Why Do Oil Tankers Spend So Much Time Sailing Empty?
News

Oil prices slide as Trump says Iran strikes are ‘unlikely’

Beijing calls tariffs “blackmail”
News

China extends pause on 24% US Tariffs

AI poised to pass human tests in 5 years, CEO says
News

Nvidia stock plummets 7% amid Jensen Huang controversy

U.S. payrolls increased by 178,000 in March, while unemployment remains at 4.3%
News

October jobs report smashes estimates, adding 165,000

Elon Musk loses reinstatement bid for $56 billion pay package
News

Midterms see Tesla and SpaceX lose over $420 billion in combined market cap

Airbnb rises on revenue win, strong Q3 outlook
News

Airbnb shares jump 12% on upbeat outlook

Visa and Mastercard to ramp up merchant fees
News

Visa forecasts U.S. holiday spending to rise 4.5% 

ConocoPhillips to buy Marathon Oil
News

ConocoPhillips CEO raises dividend after Q3 results

Tripadvisor CEO to step down
News

Tripadvisor CEO to step down

McDonald’s announces Skye Anderson as new U.S. Regional President
News

McDonald’s posts impressive Q3, despite U.S. sales decline

No Result
View All Result

Recent Posts

  • How board dynamics and behaviours impact governance
  • Oil prices slide as Trump says Iran strikes are ‘unlikely’
  • AI Governance Principles for Boards
  • China extends pause on 24% US Tariffs
  • Nvidia stock plummets 7% amid Jensen Huang controversy

Archives

Categories

  • Art & Culture
  • Business
  • CEO Interviews
  • CEO Life
  • Editor´s Choice
  • Entrepreneur
  • Environment
  • Food
  • Health
  • Highlights
  • Industry
  • Innovation
  • Issues
  • Management & Leadership
  • News
  • Opinion
  • PrimeZone
  • Printed Version
  • Technology
  • Travel
  • Uncategorized

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

  • CONTACT
  • GENERAL ENQUIRIES
  • ADVERTISING
  • MEDIA KIT
  • DIRECTORY
  • TERMS AND CONDITIONS

Advertising –
advertising@ceo-na.com

110 Wall St.,
3rd Floor
New York, NY.
10005
USA
+1 2125 9933 0330

UK
Collingwood Buildings,
38 Collingwood Street,
Newcastle Upon Tyne
NE1 1JF

  • News
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life

  • CONTACT
  • GENERAL ENQUIRIES
  • ADVERTISING
  • MEDIA KIT
  • DIRECTORY
  • TERMS AND CONDITIONS

Advertising –
advertising@ceo-na.com

110 Wall St.,
3rd Floor
New York, NY.
10005
USA
+1 2125 9933 0330

UK
Collingwood Buildings,
38 Collingwood Street,
Newcastle Upon Tyne
NE1 1JF

CEO North America © 2024 - Sitemap

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • News
    • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.